Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05241834
Title A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Eli Lilly and Company
Indications

thyroid gland medullary carcinoma

Advanced Solid Tumor

Therapies

LOXO-260

Age Groups: adult | child | senior
Covered Countries USA

Additional content available in CKB BOOST